Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › VEGF antagonist formulations suitable for intravitreal administration

VEGF antagonist formulations suitable for intravitreal administration

US Patent 11732024 · Granted Aug 22, 2023

Estimated economic value: $115,236,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activin a antibody formulations and methods of use thereof2025
Devices and methods for overfilling drug containers2025
Devices and methods for overfilling drug containers2025
Methods for predicting and modulating glycation of a protein2025
VEGF antagonist formulations suitable for intravitreal administration2025
VEGF antagonist formulations suitable for intravitreal administration2025
VEGF antagonist formulations suitable for intravitreal administration2025
VEGF antagonist formulations suitable for intravitreal administration2025
Modified urokinase-type plasminogen activator polypeptides and methods of use2025
Methods for treating angiogenic eye disorders with high doses of VEGF receptor f2024
Complement factor I-related compositions and methods2024
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodie2024